Rapid Evaluation for Stroke Outcomes Using Lytics in Vascular Event (RESOLVE) Registry and Implementation Quality Improvement Study
NCT01864928 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Acute Ischemic Stroke. The registry lists an enrollment of 192 participants. The registry lists a start date of 31 Jul 2013 and a primary completion date of 31 Dec 2016. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01864928 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Saint Luke's Health System |
| Enrollment | 192 |
| Conditions | Acute Ischemic Stroke |
| Start | 31 Jul 2013 |
| Primary completion | 31 Dec 2016 |
| Study completion | 31 Dec 2016 |
| Last update posted | 19 Oct 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Carole Decker, MSN, PhD
St. Luke's Hospital, Kansas City, Missouri
Study Director - John A Spertus, MD, MPH
St. Luke's Hospital, Kansas City, Missouri
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01864928
Each answer restates registry values shown on this page.
What is NCT01864928?
NCT01864928 is an observational study sponsored by Saint Luke's Health System. It studies Acute Ischemic Stroke.
Who leads NCT01864928?
The registry names Carole Decker, MSN, PhD (study director, St. Luke's Hospital, Kansas City, Missouri) and John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as overall officials.
When did NCT01864928 end?
The registry lists a primary completion date of 31 Dec 2016 and a study completion date of 31 Dec 2016. The sponsor last updated the record on 19 Oct 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.